Affordable Access

In vitro generation of cytolytic T cells against human melanoma cells overexpressing HDM2.

Authors
Type
Published Article
Journal
Anticancer research
Publication Date
Volume
24
Issue
4
Pages
2141–2151
Identifiers
PMID: 15330154
Source
Medline
License
Unknown

Abstract

These data suggest that HDM2441 may be exploited for broad-spectrum DC-based trials against metastatic melanomas overexpressing HDM2, and point out that the efficacy of such immunotherapeutical approaches may be limited via T cell apoptosis.

Statistics

Seen <100 times